Alzheimer's News Today | Institute of Medicine Vitamin D Intake Recommendation Was Miscalculated Far ... Alzheimer's News Today Dr. Llewellyn is a Chartered Psychologist and an Associate Fellow of the British Psychological Society whose research focuses on risk factors, overlapping pathologies and functional consequences of Alzheimer's disease and dementia, particularly where ... |
Month: March 2015
People with dementia in hospital struggling with undiagnosed pain, study finds – Alzheimer’s Society
People with dementia in hospital struggling with undiagnosed pain, study finds Alzheimer's Society The research, funded by Alzheimer's Society and led by UCL's Dr Liz Sampson, saw academics assess people with dementia in two UK hospitals. Participants were assessed every four days for self-reported pain and also observed by the study team over the ... |
Police, firefighters train to help Alzheimer’s, dementia patients – KFVS
Police, firefighters train to help Alzheimer's, dementia patients KFVS He acknowledged alarming statistics that 70 percent of people with dementia will wander from their home at some point. "These are people that have served our communities that have done a lot for us," said Chief Hunt. "They are our family members too ... |
Is drug industry on the right track in Alzheimer’s research? – SFGate
NBCNews.com | Is drug industry on the right track in Alzheimer's research? SFGate The researchers examined more than 3,600 brains from patients who died at different stages of dementia, with Alzheimer's confirmed in almost 1,400. Measuring amyloid and tau in the brains at various stages of disease progression allowed them to ... Ethicist: Why a New Alzheimer's Drug Isn't A No-Brainer Can Biogen Change How We View Alzheimer's Disease? |
Ethicist: Why a New Alzheimer’s Drug Isn’t A No-Brainer – NBCNews.com
NBCNews.com | Ethicist: Why a New Alzheimer's Drug Isn't A No-Brainer NBCNews.com In a very early stage safety test aducanumab slowed the cognitive decline and dementia associated with Alzheimer's in people. On the Mini Mental Status Exam, a widely used measure of cognitive function, people at risk of Alzheimer's who got a placebo ... Alzheimer's debate revived as Biogen's drug trial advances Potential Alzheimer's drug further backs protein hypothesis |
‘MIND’ Your Diet, and Protect Against Alzheimer’s – Live Science
Live Science | 'MIND' Your Diet, and Protect Against Alzheimer's Live Science Alzheimer's disease, the most common form of dementia, affects more than 40 million people globally, according to Alzheimer's Disease International. Among developed nations, the prevalence rates tend to be highest in North America and northern Europe ... The MIND diet provides some good news in the fight against Alzheimer's New MIND diet lowers risk of developing Alzheimer's Disease by 53 percent! Food for the mind |
Alzheimer’s Debate Revived Even as Biogen’s Drug Trial Advances – Bloomberg
Bloomberg | Alzheimer's Debate Revived Even as Biogen's Drug Trial Advances Bloomberg The researchers examined more than 3,600 brains from patients who died at different stages of dementia, with Alzheimer's confirmed in almost 1,400. Measuring amyloid and tau in the brains at various stages of disease progression allowed them to ... Alzheimer's: Tau, Not Amyloid, Is The Primary Driver Study: Progression of dysfunctional tau protein drives cognitive decline in ... Mayo Clinic Study of Thousands of Brains Reveals Tau as Driver of Alzheimer's ... |
5 Documentaries About Memory Loss, Dementia, and Alzheimers – Newsmax
5 Documentaries About Memory Loss, Dementia, and Alzheimers Newsmax Millions of Americans will experience some form of memory loss, dementia and Alzheimer's, as the debilitating and fatal brain disorder places incredible strain on everyone involved. Alzheimer's may affect as many as 5 million United States citizens ... |
Business in fight against dementia – The Australian Financial Review
The Australian Financial Review | Business in fight against dementia The Australian Financial Review Genworth Mortgage Insurance chairman Richard Grellman has first-hand experience of the high levels of care and support needed for people affected with dementia. His wife Suellen was diagnosed four years ago with advanced young-onset Alzheimer's ... Hopeful news from -- and for -- Alzheimer's researchers Public Release: 23-Mar-2015 Research identifies novel steps in dementia ... |
Alzheimer’s drug trial shows promising early results – The Guardian
The Guardian | Alzheimer's drug trial shows promising early results The Guardian But the dearth of drugs to halt or even slow the progress of dementia – of which Alzheimer's is the most common type – means that any positive results will be greeted with enthusiasm. In the trial, conducted primarily to ensure the drug was safe and ... Dementia Silver Bullet? New Drug Might Slow Alzheimer's Biogen's Alzheimer's drug shows early promise Biogen's Alzheimer's drug slows mental decline in early study |